86.21.Z - General medical practice activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.B - Emergency ambulance activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | 0 | -20 | ∞ |
EBITDA | 0 | -20 | ∞ | |
Short time liabilities | 0 | 15 | -∞ | |
Income tax | 0 | 0 | ||
Equity capital | 5 | 5 | -15 | -400 |
Operating profit (EBIT) | 0 | -20 | ∞ | |
Assets | 5 | 5 | 0 | -100 |
Net profit (loss) | 0 | 0 | -20 | ∞ |
Cash | 0 | 0 | 0 | |
Net income from sale | 0 | 0 | 0 | |
Liabilities and provisions for liabilities | 0 | 0 | 15 | -∞ |
Working assets | 5 | 5 | 0 | -100 |
Depreciation | 0 | 0 | 0 | |
Basic operational activity income | 0 | 0 | ||
% | % | % | p.p. | |
Profitability of capital | 0 | 0 | 133,3 | 133,3 |
Equity capital to total assets | 100 | 100 | 0 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 2 147 483 648 | 2 147 483 648 | |
Current financial liquidity indicator | 0 | |||
Net dept to EBITDA | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane